Related Experiment Video
Updated: May 7, 2026

Testing Cancer Immunotherapeutics in a Humanized Mouse Model Bearing Human Tumors
Published on: December 16, 2022
Cancer, aging and immune reconstitution
Stefania Zanussi1, Diego Serraino, Riccardo Dolcetti
1National Cancer Institute, IRCCS, Aviano, Via Franco Gallini 2, 33081 Aviano (PN), Italy. dirscienti@cro.it.
Aging significantly impairs the immune system, increasing cancer risk and reducing treatment effectiveness in older adults. Understanding these age-related immune changes is crucial for developing better cancer therapies.
Area of Science:
- Immunology
- Gerontology
- Oncology
Background:
- Aging is a complex process affecting multiple physiological systems, including the immune system.
- Age-related immune system decline (immunosenescence) is linked to increased cancer incidence and poorer outcomes.
- Inflammatory status during aging can promote immune suppression and tumor growth.
Purpose of the Study:
- To describe age-dependent alterations in innate and adaptive immunity.
- To explore the impact of immune aging on antitumor responses in elderly cancer patients.
- To evaluate the potential of cellular immunotherapy and vaccination in older cancer patients.
Main Methods:
- Review of preclinical studies and clinical observations on aging, immunity, and cancer.
- Analysis of age-associated alterations in antitumor immunity.
- Examination of immune reconstitution after chemotherapy and stem cell transplantation in older individuals.
Main Results:
- Both innate and adaptive immunity are compromised with aging, leading to immune suppression and increased tumor growth.
- Delayed immune reconstitution in older patients post-transplantation increases susceptibility to infections and tumor relapse.
- Cellular immunotherapy and vaccination show promise for improving outcomes in elderly cancer patients, though clinical data is limited.
Conclusions:
- Immune system aging detrimentally affects cancer response in older patients.
- Distinguishing age-related immune changes from cancer-induced immunosuppression is challenging.
- Longitudinal studies and advanced immunological techniques are needed to clarify these complex interactions.
Related Concept Videos
Immunodeficiency Diseases
There are three main causes of immunodeficiency...
Tumor Immunotherapy
Cell-mediated Immune Responses
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Adaptive Mechanisms in Cancer Cells
Mechanisms of Retrovirus-induced Cancers

